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In recent years, Spain has implemented a number of air quality control measures that are 
expected to lead to a future reduction in fine particle concentrations and an ensuing positive 
impact on public health.  
Objectives  
We aimed to assess the impact on mortality attributable to a reduction in fine particle levels in 
Spain in 2014 in relation to the estimated level for 2007.  
Methods 
To estimate exposure, we constructed fine particle distribution models for Spain for 2007 
(reference scenario) and 2014 (projected scenario) with a spatial resolution of 16x16 km
2
. In a 
second step, we used the concentration-response functions proposed by cohort studies carried 
out in Europe (European Study of Cohorts for Air Pollution Effects and Rome longitudinal 
cohort) and North America (American Cancer Society cohort, Harvard Six Cities study and 
Canadian national cohort) to calculate the number of attributable annual deaths corresponding 
to all causes, all non-accidental causes, ischemic heart disease and lung cancer among 
persons aged over 30 years (2005-2007 mortality rate data). We examined the effect of the 
Spanish demographic shift in our analysis using 2007 and 2012 population figures.  
Results 
Our model suggested that there would be a mean overall reduction in fine particle levels of 1 
µg/m
3 
by 2014. Taking into account 2007 population data, between 8 and 15 all-cause deaths 
per 100,000 population could be postponed annually by the expected reduction in fine particle 
levels. For specific subgroups, estimates varied from 10 to 30 deaths for all non-accidental 
causes, from 1 to 5 for lung cancer, and from 2 to 6 for ischemic heart disease. The expected 
burden of preventable mortality would be even higher in the future due to the Spanish 
population growth. Taking into account the population older than 30 years in 2012, the absolute 
mortality impact estimate would increase approximately by 18%.  
Conclusions 
Effective implementation of air quality measures in Spain, in a scenario with a short-term 
projection, would amount to an appreciable decline in fine particle concentrations, and this, in 
turn, would lead to notable health-related benefits. Recent European cohort studies strengthen 
the evidence of an association between long-term exposure to fine particles and health effects, 
and could enhance the health impact quantification in Europe. Air quality models can contribute 
to improved assessment of air pollution health impact estimates, particularly in study areas 
without air pollution monitoring data. 
 














































































































































The epidemiological literature has signalled that exposure to air pollution, especially fine 
particles of less than 2.5 µm in aerodynamic diameter (hereinafter referred to as "fine 
particles"), can lead to cases of immediate (acute) or delayed (chronic) premature death, from 
cardiopulmonary diseases in particular (Pope et al., 2006; Valavanidis et al., 2008). 
Epidemiological cohort studies, both in Europe (Beelen et al., 2008; Cesaroni et al., 2013) and 
in North America (Pope et al., 2002; Turner et al., 2011), have estimated the long-term health 
risk posed by exposure to air pollution. The Harvard Six Cities study reported a 14% increase in 
long-term all-cause mortality for every increase of 10 µg/m
3
 in fine particle concentration 
(Lepeule et al., 2012). This last study and other recent European cohort studies (Cesaroni et al., 
2013; Raaschou-Nielsen et al., 2013a) have reported increases in long-term mortality even at 
fine particle levels below the ambient air quality standards. 
 
Evidence from a growing body of epidemiological studies has historically supported critical 
environmental policy decisions (Fann et al., 2011). Assessments of interventions which improve 
air quality show that a decrease in fine particle levels is accompanied by substantial health 
benefits (van Erp et al., 2008). By way of example, the 1990 ban on the use of coal in Dublin 
(Ireland) led to a 70% reduction in monthly mean particle concentrations, and a 6%, 15% and 
10% decrease in all-cause, respiratory and heart disease mortality rates, respectively (Clancy et 
al., 2002).  
 
Health impact assessment makes it possible to quantify the effect that public policies may have 
on the health of the population (WHO, 2000). Quantitative risk assessment methods are useful 
in providing point estimates, or a range of estimates, for the health risks associated with a 
variety of hazards, including air pollution, and are often used in health-based policy making 
(O'Connell et al., 2009). For health impact assessment purposes, air quality information must be 
linked to the population subject to the exposure. The application of air quality models helps 
examine potential air quality impacts and related health effects associated with emissions, and 
develop country-wide health impact assessment, especially in study areas without air pollution 
monitoring data (Dhondt et al., 2012).  
 
In Spain, the Air Pollution Risk Assessment System (Sistema de Evaluación de Riesgos por 
Contaminación Atmosférica - SERCA) research project pioneered a nation-wide health impact 
assessment of air pollution, based on a reduction in fine particle levels in 2011 vis-à-vis 2004, 
as a result of a series of air quality control measures. Although such policy measures are not 
necessarily focused on health, they could nonetheless have an indirect effect on health. This 
study estimated that 1,718 annual deaths were attributable to an average annual reduction of 
0.7 µg/m
3
 in fine particle levels in Spain (Boldo et al., 2011). The experience and knowledge 




































































assessment, with more accurate estimates and a time horizon extended to 2014. This study 
now shows the impact of various air quality control measures on mortality, taking fine particle 
concentrations as an overall indicator of air pollution (WHO, 2006). In addition to total mortality, 
the study analyses the impact of changes in fine particle levels on two of the leading principal 
causes of death in Spain (INE, 2011), namely, ischemic heart disease and lung cancer.  
 
2. Materials and methods 
 
Quantitative health impact assessment estimates were derived by linking together: (i) estimates 
of how proposed policies would affect population exposures; (ii) background mortality rates; 
and, (iii) concentration-response functions, typically expressed as percentage change in health 
effect per unit of exposure. This is an established approach when quantifying health impacts 
mediated by air pollution (O'Connell et al., 2009). 
 
2.1. Air pollution scenarios: 2007-2014  
 
We defined a reference scenario corresponding to 2007, based on data drawn from the official 
National Emission Inventory for Spain (MARM, 2010), and designed a projected scenario to 
simulate air pollution distribution in 2014 in a case where air quality control measures planned in 
2007 proved successful. This projected scenario was based on the reference scenario defined 
for Spain using emission projection methodology (Lumbreras et al., 2008), and assumed 
significantly decreased emissions of fine particle precursors (e.g., 51% reduction in primary fine 
particle emissions) resulting from technological measures targeting the road transport sector, 
industry and power generation (Table 1). The projected scenario reflected the most likely future 
situation, since it included expected outcomes from official plans and specific legislation (see 
Supplementary Material, Table 1). Accordingly, the emissions and, by extension, the changes in 
air quality reported in this paper may be regarded as the most feasible evolution over the period 
considered. These measures affect a wide number of pollutants, with reduction in fine particle 
concentrations being chosen as an overall indicator of the health benefits to be obtained as a 
result of an improvement in air quality.  
 
For both scenarios, emissions were initially processed using the Sparse Matrix Operator Kernel 
Emissions (SMOKE) modelling system (Borge et al., 2008). The US Environmental Protection 
Agency's (US EPA) Community Multiscale Air Quality model (CMAQ v4.6) was then applied 
(Byun et al., 2006) to simulate fine particle (μg/m
3
) concentration levels for the entire Iberian 
Peninsula, Balearic Islands, Ceuta and Melilla, using a grid with a spatial resolution of 16×16 
km
2
 (4,500 cells). Since the SERCA modelling domain was centred on the Iberian Peninsula, 
the Canary Islands were not included for estimation purposes. The Community Multiscale Air 
Quality (CMAQ) model is a next-generation 3D Eulerian Chemical-transport model which 




































































approach. Interactions among pollutants and processes are taken into account (emissions, 
physical transport and deposition phenomena, photochemical reactions, gas-particle 
interactions, secondary aerosols, etc.). Detailed information regarding the working principles 
and model formulation can be found elsewhere (Byun et al., 2006; Byun et al., 1999). The 
CMAQ modelling results provided the basis for the health impact estimates. Using the 
Environmental Benefits Mapping and Analysis Programme (BenMAP: 
http://www.epa.gov/air/benmap/), a health impact assessment tool designed by the US EPA, air 
pollution changes in each cell were calculated by subtracting air pollution levels resulting from 
CMAQ models (projected minus reference). 
 
2.2. Study population and mortality rates for the reference scenario 
 
For each town in Spain (8,109 municipalities), the Spanish National Statistics Institute furnished 
population data and the number of deaths corresponding to all-cause mortality, including 
external causes (International Classification of Diseases, 10
th
 revision (ICD-10), codes A00-
Y98), all non-accidental causes (ICD-10 codes A00-R99), ischemic heart disease (ICD-10 
codes I20-I25) and lung cancer (ICD-10 code C33-C34), broken down by 5-year age groups, for 
the period 2005-2007, to make for more stable estimates. Lung cancer deaths included deaths 
due to malignant neoplasm of the trachea, bronchus, and lung. Mortality and municipal 
population data were used to calculate the mortality rates for each town. In addition, we also 
used municipal population data for year 2012 to consider the effect of the Spanish demographic 
shift on this health impact assessment. 
 
In Spain, municipal centroids are computed by taking only the inhabited area of the designated 
town into account, and are situated in the centre of the most populous zone. Each municipality 
was therefore assigned the geographical coordinates corresponding to its centroid, which were 
then deemed to be representative points of the location of the town's population. An overlapping 
grid identical to that used for the air quality models (spatial resolution of 16×16 km
2
) was then 
applied, using geographic information system software to identify which centroids were located 
in each cell. In those cells that included more than one municipal centroid, mortality and 
population data were aggregated to obtain a unique cell value. Air pollution changes in each cell 
calculated as described above, were applied to all the centroids included. Figure 1 shows the 
spatial distribution of the population, and includes a close-up of two specific Autonomous 
Regions, Madrid and Murcia. Towns in the Madrid Region tend to be smaller in terms of 
geographical area than those in Murcia, thereby making it possible for at least one centroid 
representative of the corresponding population to be included in all the grid squares. In Murcia, 
however, municipalities cover a greater surface area, so that there are blank squares that do 
not include population centroids.   
 





































































We estimated attributable deaths using health impact functions based on studies of long-term 
exposure to fine particles conducted on large cohorts in Europe (Cesaroni et al., 2013; 
Raaschou-Nielsen et al., 2013a) and North America (Crouse et al., 2012; Krewski et al., 2009; 
Lepeule et al., 2012; Pope et al., 2004; Pope et al., 2002). We calculated the mortality impact of 
a reduction in fine particles for all-causes (Krewski et al., 2009; Lepeule et al., 2012; Pope et al., 
2002), all non-accidental causes (Cesaroni et al., 2013; Crouse et al., 2012), ischemic heart 
disease (Cesaroni et al., 2013; Crouse et al., 2012; Krewski et al., 2009; Pope et al., 2004) and 
lung cancer (Cesaroni et al., 2013; Krewski et al., 2009; Lepeule et al., 2012; Pope et al., 2002; 
Raaschou-Nielsen et al., 2013a). The concentration-response function relates a change in fine 
particle concentration to a change in mortality. In order to be consistent with the selected 
concentration-response functions, all mortality analysis targeted the age group examined in 
each cohort study. Table 2 summarizes the main characteristics of these cohort studies and 
their concentration-response functions, expressed as hazard ratios per 10 µg/m
3 
increase in fine 
particles. 
 
Several concentration-response functions used for this health impact assessment analysis were 
not included in the BenMAP. In these cases, the values of the regression coefficients (ß), which 
is the natural logarithm of the hazard ratio for an increase in concentrations of fine particles of 1 
µg/m
3
, and their standard errors were calculated on the basis of the published confidence 
interval of concentration-response functions for specific causes (Abt Associates Inc, 2010a) and 
were then introduced into the BenMAP software.  
 
2.4. Estimation of attributable fine particle health impact  
 
The BenMAP tool is compatible with the US EPA's Community Multiscale Air Quality model. 
Following the application of Community Multiscale Air Quality software, the model's outputs 
were processed and introduced into the BenMAP, in order to estimate crude figures of all-
cause, all non-accidental cause, ischemic heart disease and lung cancer mortality attributable to 
the changes in air quality. For each grid cell within Spain's territorial boundaries, we therefore 
supplied average population figures for the period 2005-2007, mortality rates broken down by 5-
year age group, and estimated fine particle levels for 2007 and 2014. We repeated the analyses 
using the Spanish population in 2012.  
 
Assuming that the entire population was exposed to fine particle air pollution, attributable deaths 
were calculated in absolute and relative numbers on a grid cell-by-cell basis in Spain. The 
following equation was used to calculate the change in the mortality rate based on differences in 








































































where Y0 is the mortality rate at the reference scenario; HR, the hazard ratio for an increase in 
concentrations of fine particles of 1 µg/m
3
, as derived from the selected cohort studies (Table 2); 
∆Q, the change in estimated air pollutant concentration between the reference and projected 
scenario; and P, the potentially affected population at the reference scenario.  
 
The BenMAP software calculates a distribution of point estimates in each grid cell of the number 
of attributable deaths associated with changes in fine particles between the two scenarios 




 percentiles of this 
distribution to provide a range of uncertainty for health impact assessment results. National 
figures of deaths attributable to fine particle reduction were obtained by adding up all the cell 
estimates. When the lower estimate of the concentration-response function was below 1, as 
was the case for the effect of fine particles on lung cancer mortality in the framework of the 
European Study of Cohorts for Air Pollution Effects (Raaschou-Nielsen et al., 2013a), we 
considered that the minimum health benefits of reducing air pollution would be null, and set the 
lower limit of the range to 0. The methodology used in this study is described in detail elsewhere 




In Spain, the main sectors responsible for emissions of primary fine particles in 2007 and 2014 
were road transport and other mobile sources, machinery, non-industrial combustion plants, and 
combustion in the energy, transformation, and manufacturing industries. The combination of all 
these accounted for 94% of emissions of this pollutant in 2007. Among these sectors, note 
should be taken of transport (both road and off-road) with 58% of total fine particle emissions in 
2007. By implementing air quality control measures, it is precisely these sectors, along with the 
combustion sector (in the energy, transformation, and manufacturing industries), that could 
most reduce their emissions, i.e., by 69% and 59% respectively (Table 1).  
 
With regard to the air quality simulation, the national average fine particle concentration in the 
reference scenario (2007) was 6.3 µg/m
3
; the result of modelling for 2014 showed a generalised 
improvement throughout the territory, with the average fine particle concentration being reduced 
to 5.4 µg/m
3
. The difference between the two scenarios amounts to an overall reduction of 
approximately 15% or 1 µg/m
3
 (range 0.3-4.3 µg/m
3
) in Spain. If air quality control measures 
were successfully implemented, reductions would be achieved in especially important fine 
particle levels, particularly in large Spanish cities such as Madrid (4.3 µg/m
3
), Barcelona and the 
Greater Barcelona area (3.5 µg/m
3
), and Valencia (3 µg/m
3
). Figure 2 displays the difference in 
simulated average fine particle concentration (µg/m
3
) between the projected (2014) and 





































































Spanish population was heterogeneously distributed across 8,019 towns, though most of these 
subjects tend to congregate in large cities (Figure 1). Spain had an annual population over the 
age of 30 years of 27,953,825 in 2007, and 30,889,710 in 2012. Table 3 shows the average 
annual number of deaths (period 2005-2007) for each selected mortality indicator, as well as 
population figures in 2007 and in 2012 according to the specific age range used in each cohort 
study.  
 







 percentiles) and crude annual rates per 100,000 population, 
which could be potentially prevented by the fine particle reduction scenario in Spain. Using 2007 
population figures and depending on the selected concentration-response functions, our 
analysis indicated a number of attributable deaths from all causes ranging from 2,365 to 4,163, 
corresponding to crude rates from 8 to 15 deaths delayed per 100,000 population, and it would 
account for approximately 0.7-1.1% of the total number of annual deaths in this population. Of 
the estimated mortality attributable to all causes, between 186 and 777 annual deaths (1-5 
deaths per 100,000 population) were due to lung cancer and between 654 and 1,817 annual 
deaths (2-6 deaths per 100,000 population) were due to ischemic heart disease. In relative 
terms, the impact of air pollution was greater when cause-specific mortality coefficients were 
used, i.e., 1.0-6.5% of annual deaths due to lung cancer and 1.8-5.1% of annual deaths due to 
ischemic heart disease.  
 
On the other hand, we explored the effect of using different estimates from the same cohort 
study, i.e. American Cancer Society cohort (Krewski et al., 2009; Pope et al.,  2004; Pope et al., 
2002). We found a decrease by 43% for all causes (2,365 deaths, range: 1,306-3,420), by 22% 
for lung cancer (389 deaths, range: 180-518), and by 15% for ischemic heart disease (972 
deaths, range: 761-1,181), when using the Krewski’s concentration-response functions 
compared to those of Pope.  
 
Finally, in relation to the 2012 population figures, our findings in terms of postponed deaths 
would increase by 18% for all causes, by 10% for lung cancer, and by 17% for ischemic heart 
disease, compared to the values using 2007 population data and Pope’s estimates. In contrast, 
when we used the Harvard Six Cities concentration-response functions and its younger 
population range (Lepeule et al., 2012), the increase was limited to 5% for all-causes and to 7% 
for lung cancer.  
 
Figure 3 depicts the geographical distribution of the absolute number of annual attributable 
deaths and the annual crude rate of attributable deaths per 100,000 population expected in 
2014 using population in 2007, and estimated using Pope's concentration-response functions 
(Pope et al., 2004; Pope et al., 2002). In terms of absolute numbers, the greatest health benefits 




































































capitals, where the highest fine particle reduction concentrations are usually found. This is 
because of the wide difference in concentrations between the two scenarios and the great 
number of inhabitants that congregate in these population centres. In the country's capital, 
Madrid (2,146,146 inhabitants aged over 30 years), a total of 650, 168 and 80 annual deaths 
due to all causes, ischemic heart disease and lung cancer respectively (50
th
 percentile) was 
estimated to be attributable to a 4.3 µg/m
3 
reduction in fine particles. Something similar would 
occur in Barcelona and its outlying towns (Hospitalet de Llobregat, Prat de Llobregat, Sant Adrià 
de Besòs and Venturada) (with 1,346,419 inhabitants aged over 30 years), where there were an 
estimated 292, 69 and 37 annual deaths due to all causes, ischemic heart disease and lung 
cancer respectively. Other towns situated in the Greater Barcelona area and in Valencia and the 
Greater Valencia area also registered a reduction in fine particles of over 3 µg/m
3
, so that they 
made a substantial contribution to the number of deaths attributable to air pollution. 
Nevertheless, the geographical distribution of the crude mortality rates indicates that the 
greatest health benefits in relative terms would be felt in certain areas of the Autonomous 




This study reports the mortality impact in Spain expected in 2014, resulting from a mean 
reduction of 1 µg/m
3
 in fine particle concentrations. Taking into account 2007 population data, 
between 8 and 15 all-cause deaths per 100,000 population could be postponed annually by the 
expected reduction in fine particle levels. For specific subgroups, estimates varied from 10 to 30 
deaths for all non-accidental causes, from 1 to 5 for lung cancer, and from 2 to 6 for ischemic 
heart disease. For each mortality indicator, our results varied depending on the selected cohort 
studies, which included different age range and provided different hazard ratios.  
 
If we consider the Spanish population growth occurred from 2007 to 2012 and Pope’s 
estimates, the mortality impact would increase by 18%, 10% and 17% for all causes, lung 
cancer and ischemic heart disease, respectively (Pope et al., 2004; Pope et al., 2002). We 
should keep in mind that the American Cancer Society cohort included people over 30, while 
the Harvard Six Cities cohort recruited participants between 25 and 74 years old. This age 
variation could explain the lower increases -close to 5%- obtained applying the Harvard cohort 
risk functions to our data. Differences between both estimates could highlight the relevance of 
Spanish population ageing in our health impact assessment.  
 
The results of this health impact assessment are in line with other previously conducted studies, 
both national (Perez et al., 2009) and international in scope (Anenberg et al., 2010; Ballester et 
al., 2008; Pascal et al., 2013). Our findings afford new reasons for reviewing the fine-particle-
related provisions envisaged under Directive 2008/50/EC on ambient air quality and cleaner air 





































































With respect to the methodology, it should be noted that accurate assessment of population 
exposure to air pollution is crucial to estimating the health impact. This study used air quality 
models with a spatial resolution of 16x16 km
2
 and incorporated air pollution control measures 
recently implemented in Spain (see Supplementary Material, Table 1). Spatial comparisons of 
air pollution patterns are facilitated by the use of maps and are useful in health-based policy-
making. In terms of a reduction in emissions, this would primarily take place in industries, 
essentially power plants in the north-western quarter of the country and the ceramics industry in 
areas lying along the Mediterranean seaboard. Nonetheless, the most important reductions are 
expected in urban settings, and are associated with technological improvements to vehicles 
(mainly the fitting of particle filters) and the application of sustainable urban transport and/or air 
quality control plans. These measures have already been partially implemented and have 
achieved a substantial reduction in fine particle emissions (e.g., at a national level the reduction 
in fine particle emissions in the period 2007-2009 was 20% (MARM, 2011). 
 
Our projections should be valid, since fine particle reduction levels have been described in 
European countries in recent years and have been attributed to various causes. On the one 
hand, the implementation of pollution-abatement strategies in Europe is having a direct effect on 
the levels of fine particles and their various components. A recently published study has stated 
that reductions in fine particles were observed across all stations in Spain and Europe to 
varying degrees (7-49%) over the period 2002-2010 (Cusack et al., 2012). This reduction has 
been gradual and consistent over time, implying the success of cleaner anthropogenic activities. 
On the other hand, the influence of the North Atlantic Oscillation has been noted, a large-scale 
meteorological phenomenon which is most prevalent during winter and modifies the frequency 
of Saharan dust intrusions across the Iberian Peninsula (Vicente-Serrano et al., 2011). As a 
result of the negative North Atlantic Oscillation, particulate matter levels have been considerably 
lower than in other winters (Pérez et al., 2008). Lastly, the ongoing economic crisis could also 
have caused a general fall in fine particle emissions (Cusack et al., 2012) and thus changed 
ambient trace element concentrations (Arruti et al., 2011; Santacatalina et al., 2012). Since 
2008, many European countries have been in recession, which affects air pollutants through a 
reduction in activities associated with a healthy economy (e.g., increased road traffic, industrial 
processes and construction) (Cusack et al., 2012).  
 
Since reductions in air pollution occur gradually after the implementation of environmental 
policies, the appearance of any concomitant health benefits could be expected to occur in a 
similar manner. Whereas any short-term health impacts might be expected to be seen almost 
immediately, in the case of the consequences of air pollution caused by a combination of short- 
and long-term causes, it might well take some years before the ensuing health benefits would 
be observable. Moreover, risk factors can be competitive, something that could also interfere in 




































































any possible long-term impacts and benefits than those in the short term (Kunzli et al., 2001). 
Intervention studies have been conducted to estimate the reduction in risk following a decrease 
in air-pollution levels (Clancy et al., 2002; Pope et al., 1992). Taking these studies into account, 
Roosli et al. proposed an exposure-response model to quantify dynamic changes in mortality 
following increases or decreases in air-pollution levels (Roosli et al., 2005). According to these 
authors, a substantial proportion of the benefit flowing from reducing contamination levels is 
seen to occur a few years after the reduction has taken place: in percentage terms, the effect 
was estimated as being 40% in the same year and 80% within 5 years (e.g., in our study a 
range of 1,892-3,330 attributable deaths). At all events, it should be noted that, while major 
benefits are to be expected in terms of public health, the real temporal pattern of such 
incremental health benefits is unknown and difficult to assess. 
 
The choice of a concentration-response function between fine particle exposure and mortality 
can generate a considerable difference in the predicted health impact estimate at lower 
concentrations. To explore these variations, we used different hazard ratios provided by large 
cohort studies conducted in Europe (Cesaroni et al., 2013; Raaschou-Nielsen et al., 2013a) and 
North America (Crouse et al., 2012; Krewski et al., 2009; Lepeule et al., 2012; Pope et al., 2004; 
Pope et al., 2002), that could be considered the most updated evidence of the effects of long-
term exposure to fine particles on mortality. Table 2 summarizes the main characteristics of the 
selected cohort studies for this health impact assessment. These studies reported different 
concentration-response functions for fine particles-related health effects. The disparities among 
them can be due to a) the variability among different populations, i.e. disparities in susceptibility, 
baseline health conditions or lifestyles; b) the environmental conditions, such as study area 
characteristics, geographic location or pollutant mixtures; and c) the exposure assessment 
methodology. 
 
In relation to the North American cohort studies, the American Cancer Society cohort (Krewski  
et al., 2009; Pope et al., 2004; Pope et al., 2002) is usually regarded as the largest cohort study 
available to date on the long-term effects of fine particles on mortality. The estimates furnished 
by this cohort are more conservative than those reported by similar studies (Crouse et al., 2012; 
Lepeule et al., 2012), and have already been used in other health impact assessment studies 
carried out in Europe (Ballester et al., 2008; Pascal et al., 2013). The Extended follow-up of the 
American Cancer Society cohort through 2000 (18 years) (Krewski et al., 2009) supported 
earlier findings (16 years follow-up) (Pope et al., 2004; Pope et al., 2002) of a positive 
association between long-term exposure to fine particles in ambient air and increased mortality 
rates in urban centres in the United States. The analysis conducted by Krewski and colleagues 
observed a decrease in the concentration-response function estimates for deaths attributable to 
fine particles compared with that of the initial follow-up period (Pope et al., 2004; Pope et al., 
2002). According to Krewski and colleagues, the lower risk found could be due to exposure 




































































the beginning of follow-up and cohort members who moved increased over time. In addition, 
fine particles concentrations declined over the follow-up period, so assigning a single exposure 
measure would not have fully captured this temporal pattern. Finally, as the cohort ages, air 
pollution effects may decline due to the healthy survivor effect (Krewski et al., 2009). The 
American Cancer Society cohort results showed how the health effect estimates of fine particles 
changed over time. When using hazard ratios from the Updated Analysis of the American 
Cancer Society cohort (Pope et al., 2004; Pope et al., 2002), we found that 4,163 annual deaths 
could be delayed in 2014, including 500 due to lung cancer and 1,143 deaths due to ischemic 
heart disease, in a population of nearly 28 million. These last findings decreased by 43%, 22% 
and 15% respectively, when using the estimates from the Extended Analysis of the American 
Cancer Society study (Krewski et al., 2009). It is complicated to extrapolate these deviations 
when applying their estimates to target populations, and transferability issues can arise (Boldo 
et al., 2011). 
 
Several studies undertaken in Europe have also estimated concentration-response functions for 
health outcomes attributable to long-term exposure to fine particles. In this report, we have used 
the most recent results of European cohort studies (Cesaroni et al., 2013; Raaschou-Nielsen et 
al., 2013a). For lung cancer, we used the latest results of European Study of Cohorts for Air 
Pollution Effects (Raaschou-Nielsen et al., 2013a), which combined 14 long-term cohort studies 
from nine European countries. They identified a hazard ratio of 1.40 (95% CI= 0.92-2.13) for all 
lung cancers per 10 µg/m
3
 in fine particles (Raaschou-Nielsen et al., 2013a), which is similar to 
the Harvard Six Cities estimate (Lepeule et al., 2012) and that from the Canadian study (Crouse 
et al., 2012), but higher than the estimate from the American Cancer Society study (Pope et al., 
2002), and from the cohort study in Italy (Cesaroni et al., 2013).  
 
The use of Rome longitudinal study risk estimates (Cesaroni et al., 2013) could be considered a 
cautious approach, as they were lower than those reported in other European (Brunekreef et al., 
2009; Naess et al., 2007; Raaschou-Nielsen et al., 2013a) and North American settings (Crouse 
et al., 2012; Lepeule et al., 2012; Pope et al., 2002). These Italian risk functions could be more 
suitable for our health impact assessment due to the common characteristics between both 
countries. Italy and Spain share notable similarities on culture and environmental conditions, i.e. 
both are Mediterranean countries located in southern Europe. Additional similarities exist with 
respect to crucial socioeconomic indicators, such as labor markets or population educational 
attainment (Eurostat, 2013).  
 
The health impact analysis estimated that an overall reduction of 1 µg/m
3
 in fine particles by 
2014 would succeed in preventing mortality attributable to this environmental risk factor. Taking 
into account the basic demographic components (mortality, fertility and migration), Spain is 
undergoing an ageing process which is accelerated by the decreasing birth rate and negative 




































































population growth would be concentrated among the higher age groups (INE, 2012). To 
incorporate population changes into the analysis, we repeated the calculations using 2012 
population figures. Taking into account the population over the age of 30 years in 2012, the 
expected number of deaths attributable to fine particles exposure would be 4,901, a figure 
substantially higher than the one estimated using the population data in 2007 (4,163 deaths) 
(Table 3).  
 
Our study also incorporated impact analysis for mortality due to specific causes, such as 
ischemic heart disease and lung cancer, since European studies on short- and long-term 
particulate matter exposure indicate a direct association with mortality in general, and mortality 
due to cardiopulmonary disease in particular (Fajersztajn et al., 2013; Hoek et al., 2013; Pope et 
al., 2006). Our study focused on mortality because background country-wide rates of other 
health outcomes, such as hospital admissions or restricted activity days, were not available. In 
any event, further evidence has emerged of the effects of long-term exposure to fine particulate 
air pollution on diseases other than cardiovascular and respiratory diseases, such as adverse 
birth outcomes (Proietti et al., 2013), diabetes (Andersen et al., 2012; Raaschou-Nielsen et al., 
2013b), neurological development in children and neurological disorders in adults (Ruckerl et 
al., 2011). There is a need to consider new health outcomes to be examined in health impact 
assessment studies.  
 
The risk of ischemic heart disease has particularly strong and consistent associations with 
exposure to fine particles. Ischemic heart disease ranks as the leading cause of death in Spain, 
despite the fact that most of the risk factors (sedentarism, hypertension and dyslipidaemia) are 
known and modifiable. The trend in the mortality rate shows that from 1990 to 2007, risk in 
Spain fell by almost 30%, owing to improvements in treatment and lower exposure to risk 
factors (Bertomeu et al., 2008). Exposure to environmental particulate matter is another risk 
factor which potentiates cardiovascular morbidity and mortality due to acute (Peters et al., 2001) 
and chronic effects (Pope et al., 2004; Pope et al., 2002), and the mechanisms whereby this 
could cause systemic cardiovascular effects are being investigated (Bhaskaran et al., 2011; 
Brook et al., 2010). Evidence accumulated during the preceding decade indicates that the most 
important part of mortality caused by air pollution is due to cardiovascular disease, such that for 
every 10 μg/m
3 
increase in fine particles, mortality due to ischemic heart disease increases from 
10% (Cesaroni et al., 2013) to 31% (Crouse et al., 2012) in this mortality impact analysis. These 
findings have led to the proposal that exposure to these particles should be considered a new 
modifiable cardiovascular risk factor. According to our results, Spain could prevent a range of 2-
5% of mortality due to this cause if the implementation of air quality control measures were 
effective.  
 
In the case of lung cancer, smoking is considered the principal risk factor and gives rise to 




































































tumour with the highest mortality rates, among men in Spain this rate decreased by 1% per 
annum from the 1990s, while among women it increased by 3% per annum over the same 
period (Cabanes et al., 2010). Epidemiological evidence that links air pollution to mortality from 
lung cancer is robust, particularly if only adenocarcinomas of the lung are considered 
(Raaschou-Nielsen et al., 2013a). Exposure to fine particulate matter is currently recognised as 
another of the principal modifiable risk factors for lung cancer (Fajersztajn et al., 2013; Thacker 
et al., 2005). New scientific evidence supports the relationship between exposure to fine 
particles and this disease (Fajersztajn et al., 2013), and it is estimated that a 10 µg/m
3
 increase 
in fine particle concentrations is associated with a 15%-27% increase in lung cancer mortality 
(Turner et al., 2011). According to our results, Spain could prevent up to 6% of mortality due to 
this cause by reducing airborne fine particulate matter.  
 
Recently, Pope and colleagues (Pope et al., 2011) assessed the exposure–response 
relationship between fine particle exposure and cardiovascular and lung cancer mortality, 
reporting that the relationship for lung cancer (almost linear) was qualitatively different to that for 
cardiovascular mortality (nonlinear). These results are relevant, in view of the fact that health 
impact assessment studies conducted to date have tended to apply concentration-response 
functions, on the assumption of linear relationships between fine particle concentrations and the 
health effects assessed, something that might lead to the impact of exposure to low fine particle 




In conclusion, air pollution constitutes one of the most significant environmental health risks and 
gives rise to both acute and chronic effects. In view of the fact that exposure to air pollution is a 
modifiable risk and that, to a great extent, this remains outside the control of the individual, 
public authorities must assume responsibility for adopting air quality control measures based on 
available scientific evidence. Compliance with European Directive guideline values should not 
only be a public health priority, so as to minimise any risks stemming from exposure to fine 
particles, but should also be a feasible goal, achievable through the interventions implemented 
in Spain. Nevertheless, since there is no known particulate matter threshold below which 
harmful health effects disappear, to improve the population's general state of health it is 
essential to continue setting increasingly ambitious targets, aimed at seeking a maximum 




Mortality data were supplied by the Spanish National Statistics Institute under a specific 
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Combustion in energy and transformation 
industries 
13,808 5,388 -61 
02 Non-industrial combustion plants 23,048 22,516 -2 
03 Combustion in manufacturing industry 10,770 4,661 -57 
04 Production processes 5,086 4,498 -12 
05 
Extraction and distribution of fossil fuels and 
geothermal energy 
133 113 -15 
07 Road transport 33,303 14,019 -58 
08 Other mobile sources and machinery 43,369 10,092 -77 
09 Waste treatment and disposal 72 76 6 
10 Agriculture 2,848 3,951 39 
 TOTAL 132,437 65,314 -51 
 
a 
Selected Nomenclature for sources of Air Pollution 11 (Nature) was not included since no variation on natural 
sources was considered for this period.  
 
Tables
Table 2. Main characteristics of the epidemiological studies and concentration-response functions used for long-term mortality impact assessment of fine particles.   
 

























American Cancer Society 
 
Harvard Six Cities 
Canadian national cohort 
Rome longitudinal study 
Pope et al., 2002 
Krewski et al., 2009 
Lepeule et al., 2012 
Crouse et al., 2012 

























2001   
Inhalable Particle Monitoring Network and 
Aerometric Information Retrieval System 
Central monitoring stations 
Satellite-derived estimates 
Eulerian dispersion model  











American Cancer Society 
 
Harvard Six Cities 
ESCAPE Project* 
 
Rome longitudinal study 
Pope et al., 2002 
Krewski et al., 2009 
Lepeule et al., 2012
 
Raaschou-Nielsen et al., 
2013
 




























2003   
 
2001  
Inhalable Particle Monitoring Network and 
Aerometric Information Retrieval System 
Central monitoring stations 
Land-use regression models 
 
Eulerian dispersion model 








American Cancer Society 
 
Canadian national cohort 
Rome longitudinal study 
Pope et al., 2004 
Krewski et al., 2009 
Crouse et al., 2012
 























Inhalable Particle Monitoring Network and 
Aerometric Information Retrieval System 
Satellite-derived estimates 










*ESCAPE project: European Study of Cohorts for Air Pollution Effects. Data from 14 European cohort studies. Participants were recruited in the 1990s and the average follow-up was 13 years.  
   
Tables
Table 3. Long-term mortality impacts of reducing fine particle concentrations in Spain by 2014 (absolute numbers and numbers per 100,000 population). 
        Long-term health impact assessment  
    
    Based on the Spanish population in 2007  Based on the Spanish population in 2012  
Mortality 
indicator 






Annual number of 
attributable deaths 






Annual number of 
attributable deaths 




  Median 
5-95th 
percentile  
Median   Median 5-95th percentile  Median 
All causes                         
  Pope et al., 2002
 
 30-99 360,407 27,953,825 4,163 1,635 - 6,669 15 30,889,710 4,901 1,925 - 7,852 16 
 
Krewski et al., 2009
 
 2,365 1,306 - 3,420 8 2,821 1,557 - 4,080 9 
 
Lepeule et al., 2012 25-74 114,796 28,081,812 2,961 1,729 - 4,178 10 29,724,117 3,108 1,814 - 4,384 10 
All non-accidental causes                             
 
Crouse et al., 2012 >25 348,330 31,572,075 9,447 8,712 - 10,173 30 33,857,417 11,273 10,400 - 12,14 33 
  Cesaroni et al., 2013 >30 347,661 27,953,825 2,677 2,128 - 3,224 10 30,889,710 3,197 2,542 - 3,851 10 
Lung cancer 
                Pope et al., 2002  30-99 18,848 27,953,825 500 228 - 767 2 30,889,710 550 257 - 839 2 
 
Krewski et al., 2009
 
 389 180 - 518 1 432 201 - 661 1 
 
Lepeule et al., 2012 25-74 11,915 28,081,812 777 274 - 1,256 3 29,724,117 833 294 - 1,345 3 
 
Raaschou-Nielsen et al., 2013 43-73 8,870 12,279,889 589 0 - 1,157 5 14,054,059 662 0 - 1,300 5 
  Cesaroni et al., 2013 >30 18,848 27,953,825 186 50 - 321 1 30,889,710 207 55 - 357 1 
Ischemic heart disease 
 
 
              Pope et al., 2004  30-99 35,672 27,953,825 1,143 922 - 1,362 4 30,889,710 1,343 1,089 - 1,596 4 
 
Krewski et al., 2009
 
 972 761 - 1,181 3 1,159 907 - 1,408 4 
 
Crouse et al., 2012 >25 35,693 31,572,075 1,817 1,65 - 1,984 6 33,857,417 2,165 1,966 - 2,364 6 
  Cesaroni et al., 2013 >30 35,672 27,953,825 654 472 - 836 2 30,889,710 780 562 - 996 3 
 
Tables
Figure 1. Spatial distribution of Spanish population (annual average 2005-2007): detailed breakdown showing 




Figure 2. Modeled fine particle reduction (µg/m
3




Figure 3. Assessment of the annual long-term mortality impact of a reduction in fine particle levels (µg/m
3
) in Spain. 
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